By Vincent Y. Ling*
*J.D. and Masters of Bioethics Candidate, 2012, University
Excerpt from Patently Ours? Constitutional Challenges to
DNA Patents , 14 U. Pa. J. Const. L. 813 (February, 2012)
The controversy surrounding patenting deoxyribonucleic acid
WASHINGTON, D.C. - ( Mealeys ) In a divided ruling, the Federal Circuit U.S.
Court of Appeals today [August 16th] reversed a New York federal judge's determination that
composition claims related to isolated DNA molecules are patent-ineligible
products of nature and scientific principles pursuant...
On Sept. 21, 2012, a three-judge panel of the Federal Circuit in In re Droge (2011-1600) [ enhanced version available to lexis.com subscribers ] held that the claims in U.S. patent application serial no. 10/082,772 (the '772 application"), directed to a method of recombining DNA in eukaryotic...
D.C. - ( Mealey's ) Less than a year after it returned to the Federal Circuit U.S. Court of
Appeals a patent lawsuit over diagnostic test kits for determining hereditary
risk of breast and ovarian cancer, the U.S. Supreme Court on Friday announced
it will again take up the case (...